Publicaciones en las que colabora con Gema Moreno Bueno (9)

2024

  1. Fatty acid amide hydrolase drives adult mammary gland development by promoting luminal cell differentiation

    Cell Death Discovery, Vol. 10, Núm. 1

2023

  1. Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer

    Nature Communications, Vol. 14, Núm. 1

2022

  1. Gasdermin B over-expression modulates HER2-targeted therapy resistance by inducing protective autophagy through Rab7 activation

    Journal of experimental & clinical cancer research : CR, Vol. 41, Núm. 1, pp. 285

2019

  1. Therapeutic targeting of HER2–CB 2 R heteromers in HER2-positive breast cancer

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 116, Núm. 9, pp. 3863-3872

  2. Erratum: Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer (Proceedings of the National Academy of Sciences of the United States of America (2019) 116 (3863–3872) DOI: 10.1073/pnas.1815034116)

    Proceedings of the National Academy of Sciences of the United States of America

2015

  1. Role of cannabinoid receptor CB<inf>2</inf> in HER2 pro-oncogenic signaling in breast cancer

    Journal of the National Cancer Institute, Vol. 107, Núm. 6

2010

  1. Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition

    Molecular Cancer, Vol. 9

2008

  1. JunD is involved in the antiproliferative effect of Δ 9 - tetrahydrocannabinol on human breast cancer cells

    Oncogene, Vol. 27, Núm. 37, pp. 5033-5044

  2. Lysyl oxidase-like 2 as a new poor prognosis marker of squamous cell carcinomas

    Cancer Research, Vol. 68, Núm. 12, pp. 4541-4550